Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Twin Threat of OSA and Hypertension on Mortality/CV-risk and Protective Effect by Positive Airway Pressure Treatment.

NCT06930989 is registered in ClinicalTrials.gov with Vastra Gotaland Region as lead sponsor.

NCT NCT06930989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06930989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Twin Threat of OSA and Hypertension on Mortality/CV-risk and Protective Effect by Positive Airway Pressure Treatment.
Lead sponsor
Vastra Gotaland Region
Phase
Observational
Overall status
Completed
Start date
January 1, 2025
Completion date
April 30, 2025
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, mace, osa - obstructive sleep apnea, pap, survival analysis